A 360-degree overview of paediatric NAFLD: Recent insights

Slides:



Advertisements
Similar presentations
EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep
Advertisements

Depression, anemia and health-related quality of life in chronic hepatitis C Amy A. Dan, Lisa M. Martin, Cathy Crone, Janus P. Ong, Denise W. Farmer, Thomas.
Omega 3 – Omega 6: What is right for the liver? Ashraf Mohammad El-Badry, Rolf Graf, Pierre-Alain Clavien Journal of Hepatology Volume 47, Issue 5, Pages.
Volume 63, Issue 1, Pages (July 2015)
Volume 46, Issue 3, Pages (March 2007)
The impact of hepatitis E in the liver transplant setting
Kirsten Boonstra, Ulrich Beuers, Cyriel Y. Ponsioen 
Inflammasomes in liver diseases
Volume 50, Issue 4, Pages (April 2009)
Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: A systematic review  Christian Thoma, Christopher P. Day, Michael.
Volume 59, Issue 6, Pages (December 2013)
m-TOR inhibitors: What role in liver transplantation?
m-TOR inhibitors: What role in liver transplantation?
Novel insights in the interplay between inflammation and metabolic diseases: A role for the pathogen sensing kinase PKR  Nicolas Marsollier, Pascal Ferré,
The impact of hepatitis E in the liver transplant setting
Reactive oxygen species in the normal and acutely injured liver
Cédric Coulouarn, Bruno Clément  Journal of Hepatology 
Matthew T. Kitson, Stuart K. Roberts  Journal of Hepatology 
Immigration and viral hepatitis
Volume 66, Issue 1, Pages 1-4 (January 2017)
The evidence supports a viral aetiology for primary biliary cirrhosis
Living donor liver transplantation: is the hype over?
Mesenchymal stromal cell therapy for liver diseases
Reply to: “DCD consensus and futility in liver transplantation”
The place of downstaging for hepatocellular carcinoma
Cheng-Yuan Peng, Rong-Nan Chien, Yun-Fan Liaw  Journal of Hepatology 
Hepatitis C core protein – The “core” of immune deception?
Volume 61, Issue 1, Pages S108-S119 (November 2014)
Amalia Gastaldelli, Giulio Marchesini  Journal of Hepatology 
Statin use and the risk of hepatocellular carcinoma in patients at high risk: A nationwide nested case-control study  Gyuri Kim, Suk-Yong Jang, Chung.
Volume 54, Issue 5, Pages (May 2011)
Volume 61, Issue 1, Pages S69-S78 (November 2014)
Volume 62, Issue 3, Pages (March 2015)
Volume 59, Issue 3, Pages (September 2013)
Behzad Hajarizadeh, Jason Grebely, Gregory J. Dore 
EASL Clinical Practice Guidelines: Wilson’s disease
Roberto de Franchis, Aleksander Krag  Journal of Hepatology 
Volume 61, Issue 1, Pages S45-S57 (November 2014)
Stephen Locarnini, Angelos Hatzakis, Ding-Shinn Chen, Anna Lok 
The changing role of beta-blocker therapy in patients with cirrhosis
Volume 57, Issue 5, Pages (November 2012)
Volume 53, Issue 6, Pages (December 2010)
Volume 50, Issue 4, Pages (April 2009)
Cédric Coulouarn, Bruno Clément  Journal of Hepatology 
Antiviral therapy for chronic hepatitis B: Challenges in Hong Kong
Paul C. Adams, James C. Barton  Journal of Hepatology 
Immigration and viral hepatitis
Clinical Practice Guidelines of the European Association for the study of the Liver – Advancing methodology but preserving practicability  Markus Cornberg,
Global burden of alcoholic liver diseases
HCV targeting of patients with cirrhosis
Volume 64, Issue 6, Pages (June 2016)
Volume 63, Issue 1, Pages (July 2015)
Familial amyloidosis: Great progress for an orphan disease
Volume 51, Issue 2, Pages (August 2009)
The use of hemospray in portal hypertensive bleeding; a case series
Epigenetic modifications as new targets for liver disease therapies
Volume 66, Issue 4, Pages (April 2017)
m-TOR inhibitors: What role in liver transplantation?
Liver transplantation in children
Ana Lleo, M. Eric Gershwin, Alberto Mantovani, Pietro Invernizzi 
Volume 60, Issue 6, Pages (June 2014)
Pathogenesis of cholestatic hepatitis C
Genetic alterations in advanced HBV-related HCC with portal vein tumor thrombosis: Insights from next generation DNA sequencing  Roongruedee Chaiteerakij,
Chimeric mouse model of hepatitis B virus infection
Volume 54, Issue 6, Pages (June 2011)
U.P. Neumann, M. Biermer, D. Eurich, P. Neuhaus, T. Berg 
Genetics of hepatocellular carcinoma: The next generation
Thierry Gustot, Rajiv Jalan  Journal of Hepatology 
Volume 64, Issue 6, Pages (June 2016)
Volume 60, Issue 6, Pages (June 2014)
Presentation transcript:

A 360-degree overview of paediatric NAFLD: Recent insights Valerio Nobili, Gianluca Svegliati-Baroni, Anna Alisi, Luca Miele, Luca Valenti, Pietro Vajro  Journal of Hepatology  Volume 58, Issue 6, Pages 1218-1229 (June 2013) DOI: 10.1016/j.jhep.2012.12.003 Copyright © 2013 European Association for the Study of the Liver Terms and Conditions

Fig. 1 Schematic representation of the crosstalk among different organs during NAFLD development. Journal of Hepatology 2013 58, 1218-1229DOI: (10.1016/j.jhep.2012.12.003) Copyright © 2013 European Association for the Study of the Liver Terms and Conditions

Fig. 2 Schematic representation of the pathogenetic mechanism-based NAFLD armamentary. Established and potential therapies targeting a given pathway are depicted in the upper and lower part of the cartoon, respectively. Journal of Hepatology 2013 58, 1218-1229DOI: (10.1016/j.jhep.2012.12.003) Copyright © 2013 European Association for the Study of the Liver Terms and Conditions

Journal of Hepatology 2013 58, 1218-1229DOI: (10. 1016/j. jhep. 2012 Copyright © 2013 European Association for the Study of the Liver Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.